within Pharmacolibrary.Drugs.ATC.H;

model H02AB10
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 15 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 25 / 1000000,
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.004166666666666667,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Cortisone is a naturally occurring corticosteroid hormone (glucocorticoid) produced by the adrenal cortex. It is used as a replacement therapy for adrenocortical insufficiency (such as Addison's disease) and historically was used for its anti-inflammatory and immunosuppressive properties. Over time, its clinical use has largely been replaced by other synthetic corticosteroids with more favorable pharmacokinetics. It is not commonly used as a first-line therapy today.</p><h4>Pharmacokinetics</h4><p>Typical pharmacokinetic parameters estimated for an average adult without specific disease conditions, based on general glucocorticoid pharmacology due to limited direct clinical PK data for cortisone.</p><h4>References</h4><ol><li><p>Giordano, R, et al., &amp; Arvat, E (2014). Dual-release Hydrocortisone in Addison&#x27;s Disease - A Review of the Literature. <i>European endocrinology</i> 10(1) 75–78. DOI:<a href=&quot;https://doi.org/10.17925/EE.2014.10.01.75&quot;>10.17925/EE.2014.10.01.75</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29872468/&quot;>https://pubmed.ncbi.nlm.nih.gov/29872468</a></p></li><li><p>Perogamvros, I, et al., &amp; Ray, DW (2011). Corticosteroid-binding globulin regulates cortisol pharmacokinetics. <i>Clinical endocrinology</i> 74(1) 30–36. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2265.2010.03897.x&quot;>10.1111/j.1365-2265.2010.03897.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21054475/&quot;>https://pubmed.ncbi.nlm.nih.gov/21054475</a></p></li><li><p>Heazelwood, VJ, et al., &amp; Mortimer, RH (1984). Plasma cortisol delivery from oral cortisol and cortisone acetate: relative bioavailability. <i>British journal of clinical pharmacology</i> 17(1) 55–59. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1984.tb04999.x&quot;>10.1111/j.1365-2125.1984.tb04999.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6691888/&quot;>https://pubmed.ncbi.nlm.nih.gov/6691888</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end H02AB10;
